Arvinas, Inc. (ARVN) financial statements (2020 and earlier)

Company profile

Business Address 395 WINCHESTER AVE
NEW HAVEN, CT 06511
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments191188
Cash and cash equivalents123
Short-term investments178185
Receivables55
Other undisclosed current assets43
Total current assets:200196
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment74
Deposits noncurrent assets 0
Other noncurrent assets0 
Total noncurrent assets:94
TOTAL ASSETS:209199
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities97
Accounts payable23
Accrued liabilities64
Deferred revenue20
Debt10
Contract with customer, liability16
Total current liabilities:2923
Noncurrent Liabilities
Long-term debt and lease obligation42
Long-term debt, excluding current maturities22
Operating lease, liability2
Liabilities, other than long-term debt4238
Deferred revenue42
Contract with customer, liability37
Other liabilities 0
Total noncurrent liabilities:4640
Total liabilities:7563
Stockholders' equity
Stockholders' equity attributable to parent134137
Common stock00
Additional paid in capital485439
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(352)(302)
Total stockholders' equity:134137
TOTAL LIABILITIES AND EQUITY:209199

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
Gross profit:4214
Operating expenses(87)(58)
Operating loss:(46)(44)
Nonoperating income52
Investment income, nonoperating52
Interest and debt expense(0)(0)
Loss from continuing operations before equity method investments, income taxes:(41)(42)
Loss from equity method investments(25) 
Other undisclosed loss from continuing operations before income taxes(0) 
Loss before gain (loss) on sale of properties:(65)(42)
Other undisclosed net income00
Net loss:(65)(41)
Other undisclosed net income attributable to parent0 
Net loss attributable to parent:(65)(41)
Preferred stock dividends and other adjustments (198)
Net loss available to common stockholders, diluted:(65)(240)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
Net loss:(65)(41)
Comprehensive loss:(65)(41)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)
Comprehensive loss, net of tax, attributable to parent:(65)(42)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: